Journal
NATURE REVIEWS MICROBIOLOGY
Volume 12, Issue 9, Pages 612-623Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrmicro3315
Keywords
-
Categories
Funding
- Canadian Institutes for Health (CIHR)
- US National Institutes of Health (NIH) [AI083713]
- NIH [AI085761]
- Wellcome Trust
- UK Medical Research Council (MRC)
- MRC [MR/J006874/1] Funding Source: UKRI
Ask authors/readers for more resources
Citrobacter rodentium is a mucosal pathogen of mice that shares several pathogenic mechanisms with enteropathogenic Escherichia coli (EPEC) and enterohaemorrhagic E. coli (EHEC), which are two clinically important human gastrointestinal pathogens. Thus, C. rodentium has long been used as a model to understand the molecular basis of EPEC and EHEC infection in vivo. In this Review, we discuss recent studies in which C. rodentium has been used to study mucosal immunology, including the deregulation of intestinal inflammatory responses during bacteria-induced colitis and the role of the intestinal microbiota in mediating resistance to colonization by enteric pathogens. These insights should help to elucidate the roles of mucosal inflammatory responses and the microbiota in the virulence of enteric pathogens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available